Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind trial of topical sirolimus gel for cutaneous vascular malformations
jRCT2051210126Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sirolimus in venous malformation (VM), lymphangioma, lymphangiomatosis (GLA) and 2 more (3 arms), sponsored by Japan Agency for Medical Research and Development. Started Dec 2021; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
venous malformation (VM)lymphangiomalymphangiomatosis (GLA)tufted angioma (TA)kaposiform hemangioendothelioma (KHE)
Beyond the preview
Go deeper on jRCT2051210126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051210126.